Bordukova, M. et al. Generative AI and Digital twins: Shaping a paradigm shift from precision to truly personalized medicine. Expert Opin. Drug Discov., DOI: 10.1080/17460441.2025.2507376 (2025)
Withers, C.A.* et al. Natural language processing in drug discovery: Bridging the gap between text and therapeutics with artificial intelligence. Expert Opin. Drug Discov. 20, 765-783 (2025)
Bordukova, M. ; Makarov, N. ; Rodriguez-Esteban, R.* ; Schmich, F.* & Menden, M.P. Generative artificial intelligence empowers digital twins in drug discovery and clinical trials. Expert Opin. Drug Discov. 19, 33-42 (2024)
Vistoli, G.* et al. MEDIATE - Molecular DockIng at homE: Turning collaborative simulations into therapeutic solutions. Expert Opin. Drug Discov. 18, 821-833 (2023)
Farnoud, A. ; Ohnmacht, A. ; Meinel, M. & Menden, M.P. Can artificial intelligence accelerate preclinical drug discovery and precision medicine? Expert Opin. Drug Discov. 17, 661-665 (2022)
Boniolo, F et al. Artificial intelligence in early drug discovery enabling precision medicine. Expert Opin. Drug Discov. 16, 991-1007 (2021)
Baskin, I.I.* ; Winkler, D.* & Tetko, I.V. A renaissance of neural networks in drug discovery. Expert Opin. Drug Discov. 11, 785-795 (2016)
Gul, S.* & Hadian, K. Protein-protein interaction modulator drug discovery: Past efforts and future opportunities using a rich source of low- and high-throughput screening assays. Expert Opin. Drug Discov. 9, 1393-1404 (2014)
Schamberger, A.C. ; Mise, N. ; Meiners, S. & Eickelberg, O. Epigenetic mechanisms in COPD: Implications for pathogenesis and drug discovery. Expert Opin. Drug Discov. 9, 609-628 (2014)
Antonov, A.V. Mining protein lists from proteomics studies: Applications for drug discovery. Expert Opin. Drug Discov. 5, 323-331 (2010)